Details for 2017772258
Up to date per 02.04.2026
Actions
Details for 2017772258
Granted/Registered
European Patent
24.07.2019 A
11.11.2020 B1
14.09.2016
US
201662394314 P
C07K 16/28 20060101AFI20200618BHEP
Owner
AbbVie Biotherapeutics Inc.1500 Seaport Boulevard Redwood City, CA 94063US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
AFAR, Daniel E. H.12682 Roble Veneno Lane Los Altos Hills California 94022US
HARDING, Fiona A.543 Calderon Avenue Mountain View California 94041US
SAMAYOA, Josue806 E. 16th Avenue San Mateo California 94402US
Information about Fees